Loading
Insider filings for Transition Therapeutics Inc. are scarce in the SEDI feed, the latest one published on 27 November 2012. This page will fill in as new trades are disclosed. Source: insider filings from SEDI. Past trades are no guide to future returns.
Transition Therapeutics Inc. is a biopharmaceutical company focused on developing innovative treatments for neurodegenerative diseases and metabolic disorders. It is listed on the Toronto Stock Exchange under the symbol XTSE.